RxDoctor Payments Data

Aracelis Lu Brea, MD

Psychiatry · Tupelo, MSNPI 1164723318

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,226 of the $1,864 with a category attached, or 65.8%. 14 manufacturers reported payments, led by Johnson & Johnson at 50.5% of the total. 2025 is the largest year on record at $965, 4.3 times the $224 reported in 2019.

$1,864in general payments, 2019–2025

Across 63 payments — averaging $29.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$941
  • AbbVie$238
  • Otsuka America Pharmaceutical, Inc.$185
  • Teva Pharmaceuticals USA, Inc.$107
  • Takeda Pharmaceuticals U.S.A., Inc.$93
  • Bausch Health US, LLC$89
  • plus $210 from 8 others

What the payments were for

  • Travel & lodging$63834%
  • Food & beverage$1,22666%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,864 in reported general payments places this provider in the 70th percentile of 219 psychiatry providers in Mississippi.

See all psychiatry providers in Mississippi

Medicare billing

Part B allowed, 2024
$17,264
Medicare patients
11
Services billed
243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Divalproex Sodium15$1,212
Quetiapine Fumarate25$891
Clonazepam21$357
Venlafaxine Hcl ErVenlafaxine Hcl11$121
Lamotrigine11$105
Fluoxetine Hcl12$82
Lorazepam13$43

Paid to pharmacies, not to this prescriber.

Other psychiatry in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →